CDKN2B and cancer: Additionally, the 9p21.3 region, that includes in addition to CDKN2A also CDKN2B and CDKN2B-AS1, is pleiotropic and several polymorphic variants in the region spanning the three genes are susceptibility markers for several cancer types [19–24].